... 重建肠道菌群对酒精性肝炎伴慢性腹泻病人治疗作用的研究 下载全文 加入收藏夹 目的:研究酒精性肝炎(alcoholic hepatitis,AH)伴慢性腹泻病人肠道菌群的变化,观察应用益生菌制剂重建肠道菌群后对AH的治疗作用.
基于4个网页-相关网页
已经有一些研究发现了治疗酒精性肝炎成功的治疗方法，但是在最有效的治疗的用药方法上还没有达成一致的意见。
Several research studies have worked to find a successful treatment for alcoholic hepatitis, but no consensus has been reached on the most effective treatment regimen.
研究结果发现接受依那西普的中重度酒精性肝炎患者的六个月死亡率显著增高。
Research results found a significantly higher rate of six-month mortality in patients with moderate to severe alcoholic hepatitis who received etanercept.
梅奥诊所的一项新的研究发现依那西普药物治疗酒精性肝炎，一种酒精过量导致的急性肝脏炎性改变是无效的。
A new study from Mayo Clinic finds the use of the drug therapy etanercept ineffective in treating alcoholic hepatitis, an acute inflammation of the liver caused by excessive consumption of alcohol.
应用推荐